Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04054908 · ClinicalTrials.gov registry record
Gut Microbiome in Colorectal Cancer
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 50
- Enrollment target
NCT04054908: Completed study, sponsored by University of California, San Francisco.
NCT04054908 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04054908 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This is a pilot feasibility study designed to investigate the alterations in the gut microbiome that occur during the course of treatment for colorectal cancer
Primary Outcome
Feasibility and acceptability will be assessed by evaluating percentage of patients approached that consent to participate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-04-13 |
| Est. Completion | 2022-06-30 |
What the finished NCT04054908 record still lists
NCT04054908 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04054908 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04054908 about?
NCT04054908 is a clinical study titled "Gut Microbiome in Colorectal Cancer". This is a pilot feasibility study designed to investigate the alterations in the gut microbiome that occur during the course of treatment for colorectal cancer
What is the current status of trial NCT04054908?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2018-04-13. Estimated completion is 2022-06-30.
Who is sponsoring clinical trial NCT04054908?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI